| Revenue growth | Revenue ₹937 Cr, +21% YoY; prior-year coinvest base effect in Wealth. |
|---|---|
| Margins | Wealth cost-income improved ~200bps YoY; target further 100–200bps annually. |
| Order book | ECM/advisory pipeline ~40 deals, ₹85–90 Cr probability-weighted. |
| Demand visibility | Strong net flows; ECM pipeline ~40 deals; private credit launch imminent. |
| Management confidence | Confident overall; defensive on dividend suspension, leverage at 2.9x. |
Growth
Revenue +21%, H1 +20%; Wealth revenue moderated on prior-year coinvest base effect; asset services +53%.
Outlook
FY27 opex ~₹550 Cr incl. new HO ROU (~₹25 Cr); clearing yields 2.5–2.8%; dividend under review.
Risks
Leverage 2.9x above 2.5x comfort; ₹16 Cr one-time charge; ESOP cost ~₹20 Cr/quarter for four quarters.
Earnings Call Transcript filed with BSE, NSE: NUVAMA. Summary written with AI assistance from the document.
Nuvama Wealth Management Ltd: key numbers
- Share price
- ₹1,843.50
- Market cap
- ₹34,022 Cr
- Revenue (annual)
- ₹4,631 Cr
- Net profit (annual)
- ₹1,041 Cr
- P/E (TTM)
- 30.1×Sector 20.8×
- Promoter holding
- 53.40%-0.58% QoQ
- FII holding
- 19.97%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nuvama Wealth Management Ltd
All →Nuvama Wealth Management Q2 FY27 Results: Net Profit ₹303.5 Cr, Up 19.5% YoY
Nuvama Wealth Management Ltd reported revenue from operations of ₹1,366 Cr (+20.4% YoY) and net profit of ₹303.5 Cr (+19.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹303.5 Cr · +19.5% YoY
Nuvama Wealth Management Share Pledge
Catalyst Trusteeship discloses a new pledge of 3.51 crore Nuvama shares by PAG Ecstasy. Total encumbered shares rise to 9.70 crore, securing a USD 450 million facility.
- Value
- ₹4,230 Cr
Nuvama Wealth Management Share Pledge
Promoter PAGAC Ecstasy pledged 3,50,74,460 additional NWML shares for overseas borrowings. Total encumbered shares now stand at 9,69,60,340 (52.54%).
Nuvama Wealth Management Employee Stock Options
Nuvama Wealth Management allotted 33,912 equity shares upon ESOP/ESAR exercise. Post-allotment, paid-up capital increased to 18,45,49,601 shares of ₹2 face value.
Nuvama Wealth Management Board Meeting Date
Nuvama Wealth will hold a board meeting on 6 November 2026 to consider Q2 and H1 results. An earnings call follows on 9 November.
Nuvama Wealth Management Regulatory Approval
Nuvama Asset Management, a subsidiary of the company, received SEBI approval to establish a Specialized Investment Fund, enabling the launch of its Numa SIF platform.